ArticleEuropean journal of medicinal chemistry2025

Discovery of novel and selective GPR17 antagonists as pharmacological tools for developing new therapeutic strategies in diabetes and obesity.

Hu Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.